Cover Image
市場調查報告書

微晶片控制的皮下藥物輸送設備

Microchip Controlled Subcutaneous Drug Delivery Devices

出版商 Greystone Research Associates 商品編碼 558552
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
Back to Top
微晶片控制的皮下藥物輸送設備 Microchip Controlled Subcutaneous Drug Delivery Devices
出版日期: 2017年09月26日 內容資訊: 英文
簡介

本報告提供微晶片控制的皮下藥物輸送設備市場相關調查,目前市場規模,領導市場佔有率的企業,治療應用,開發者,市場成長的推動因素,影響市場的經濟、技術、規定上的要素等相關分析。

摘要整理

微晶片控制的藥物輸送

  • 設備及技術
  • 市場區隔和指標
  • 人口統計與成長
  • 市場成長的促進要素
  • 風險因素

微晶片注射設備的設計要素

  • 晶片技術
  • 感測器
  • 資料收集、數據傳送
  • 通訊
  • 資料介面

微晶片控制注射器的特徵、功能

  • 認證
  • EMR整合
  • 注射活動時間標記
  • 針注射深度、速度
  • 電源管理
  • 遠端監控
  • 可變劑量記錄
  • 無線數據傳送

微晶片控制注射設備的商業分析

  • 終端設備
  • 自動注射器
  • 一次性使用
  • 多用
  • 無針注射器
  • 筆型注射器
  • 穿戴式設備
  • 開發階段的設備

微晶片設備的治療方法,應用,及市場資料

  • 自體免疫疾病
  • 生技藥品
  • 抗體
  • 免疫治療
  • 心血管
  • 代謝疾病
  • 血液學

企業簡介

目錄
Product Code: MCD494K

As therapeutic drug markets continue to evolve, advancements in drugs and devices are producing several positive improvements. New formulations are extending drug release profiles, leading to less frequent dosing. Enhancements in syringe and injector usability are increasing the number and types of therapeutics that can be self-administered. These advances have revealed a new set of concerns. Weekly, bi-weekly and monthly dosing deprives the patient of the repetitive reinforcement that is a key tenet of self-injection safety at a time when the dangers associated with powerful drug side effects are placing a priority on the need for accurate dosing and delivery. In response, device suppliers have been developing syringes and injectors with new technology, adding capabilities that address self-administration safety concerns. Using innovative technical solutions, these device features decrease patient reliance on recall, guiding them through the medication process and reducing the risk of drug dosing errors.

Microchip Controlled Subcutaneous Drug Delivery Devices - What You Will Learn

  • What SC injection devices rely on microprocessors to control the three stages of injection, what are the device specifics, and who markets them?
  • What are the essential design factors for microchip controlled subcutaneous injection devices, what are the enabling technologies, and what are the performance criteria?
  • What is the size of the market today, who are the market share leaders, and what will the market share be in 2024?
  • What are the therapeutic applications for microchip controlled injectors, who are the developers, and what indications are they targeting?
  • What are the market drivers for microchip controlled subcutaneous drug delivery devices?
  • What are the significant economic, technology, and regulatory factors affecting the market?

Table of Contents

Executive Summary

Microchip Controlled Drug Delivery

  • Devices and Technologies
  • Market Segments and Indications
  • Demographics and Growth
  • Market Drivers
  • Risk Factors

Microchip Injection Device Design Factors

  • Chip Technology
  • Sensors
  • Data Collection & Transfer
  • Communication
  • Data Interface

Microchip Controlled Injector Features & Capabilities

  • Authentication
  • EMR Integration
  • Injection Event Time Stamp
  • Needle Injection Depth & Speed
  • Power Management
  • Remote Monitoring
  • Variable Dose Capture
  • Wireless Data Transfer

Microchip Controlled Injection Device Commercial Analysis

  • Handheld Devices
  • Autoinjectors
  • Single Use
  • Multi-use
  • Needle-free Injectors
  • Pen Injectors
  • Wearable Devices
  • Development-stage Devices

Microchip Device Therapeutics, Applications & Market Data

  • Autoimmune Diseases
  • Biologicals
  • Antibodies
  • Immunotherapeutics
  • Cardiovascular
  • Metabolic Diseases
  • Hematology

Company Profiles

Back to Top